| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |